These compounds may interact with:
Indoleamine 2,3-dioxygenase 1
Potentially involved in: carcinoma; cancer; mental depression; depressive disorder; endometriosis; inflammation; neoplasm recurrence, local; obesity; weight gain; anhedonia; drug-induced depressive state; neurodegenerative disorders; chronic depression; mammary neoplasms; active crohn's disease; breast cancer; cutaneous lupus erythematosus; cystic fibrosis; head and neck cancer; interstitial cystitis
Disease data sourced from Pharos.